Similar Items: Polypharmacy is associated with lower progression from MCI to Alzheimer's disease, with sex‐specific patterns across drug classes
- APOE‐associated disease risk and sex‐specific effects in Egyptian Alzheimer's disease: an exploratory study
- Medication Consumption Patterns and Polypharmacy among Community-Dwelling Elderly in Lomé (Togo) in 2017
- Deep contrastive learning framework identifies cell‐type‐specific drug targets in Alzheimer's disease
- Alzheimer's disease drug development pipeline: 2026
- Simulation of long‐term lecanemab treatment effect on Alzheimer's disease progression
- Apathy and resting state functional connectivity across the Alzheimer's disease continuum